Esphera SynBio
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ontario, CanadaWebsite
www.espherasynbio.caRevenue
<$5 MillionIndustry
About Esphera SynBio
Esphera SynBio Org Chart
Is Esphera SynBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Esphera SynBio recently announced quarterly report
Check if Esphera SynBio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Esphera SynBio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Esphera SynBio
Check out if Esphera SynBio is spiking on competitors!
Product Launch: Get notified when Esphera SynBio launches new products
Funding: Get notified immidiatlly once Esphera SynBio has new funding data
Esphera SynBio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Esphera SynBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Esphera SynBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Esphera SynBio.
Esphera SynBio financials insights
Gather financial insights about Esphera SynBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$2M
Esphera SynBio News & Media
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Esphera SynBio
Espheras lead application of this platform technology is the modification of tumour cells in vivo such that typically protumourigenic and immunosuppressive tumour-derived exosomes become immunostimulatory, antigen-bearing modifiers of the TME and bespoke, patient specific cancer vaccines.... Read More

